Published in Drug Law Weekly, October 7th, 2008
"The primary outcome of the included studies was bone regeneration of localized alveolar ridge defects or craniofacial defects. In six human studies, BMP-2 affected local bone...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.